Clinical Trial Update: Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia [Phase 1]

View source ↗

Summary

This entry outlines a Phase 1 clinical trial to evaluate the pharmacokinetics, safety, and tolerability of AX251 LAI in patients with schizophrenia, with the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• AX251 LAI (AX251 LAI)

Snippet

Sponsor: Anxo Pharmaceutical Co., Ltd. | Conditions: Schizophrenia | Phase 1 | Status: NOT_YET_RECRUITING